Acurx Pharmaceuticals, Inc. (ACXP) IPO — S-1 Filing, Stock & Insider Activity

Acurx Pharmaceuticals, Inc. IPO — Status & S-1 Filing

Ticker: ACXP
Status: Registered — S-1 filed with the SEC
S-1 filed: 2026-02-02
Exchange: NASDAQ
Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
Shares offered: 750,000
SEC CIK: 0001736243 · View the S-1 on SEC EDGAR →

Track every registration update on the InsiderAlpha IPO tracker.

Updated Jul 16, 2026 · Last SEC filing 2026-04-22

Acurx Pharmaceuticals, Inc. (ACXP) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-04-22. InsiderAlpha tracks every ACXP SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Acurx Pharmaceuticals, Inc. (ACXP)

SEC CIK	0001736243

90-Day SEC Filing Activity

Form 4 filings (90d)	8
Latest Form 4 filing	2026-04-22

Most-Active ACXP Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
HARRISON THOMAS L	1	—
Sailer Carl	1	—
DEAN JACK H	1	—
Donohue James J.	1	—
Scodari Joseph C	1	—

Recent Insider Filings

2026-04-22 — Sailer Carl (Director)
2026-04-22 — DEAN JACK H (Director)
2026-04-22 — Donohue James J. (Director)
2026-04-22 — HARRISON THOMAS L (Director)
2026-04-22 — Scodari Joseph C (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ACXP insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

ACXP Insider Trading — FAQ

What is the latest insider trade for ACXP?: Acurx Pharmaceuticals, Inc. (ACXP) had 8 insider filings in the last 90 days, with the most recent on 2026-04-22. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying ACXP stock?: 0 insider purchases of ACXP were filed in the last 90 days.
How many insiders are selling ACXP stock?: 0 insider sales of ACXP were filed in the last 90 days.
Where can I see ACXP SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every ACXP SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live ACXP dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.